SEARCH

SEARCH BY CITATION

References

  • 1
    McEwan M, Lins RJ, Munro SK, Vincent ZL, Ponnampalam AP, Mitchell MD: Cytokine regulation during the formation of the fetal–maternal interface: focus on cell–cell adhesion and remodelling of the extra-cellular matrix. Cytokine Growth Factor Rev 2009; 20:241249.
  • 2
    Aplin JD, Haigh T, Lacey H, Chen CP, Jones CJ: Tissue interactions in the control of trophoblast invasion. J Reprod Fertil Suppl 2000; 55:5764.
  • 3
    Snir A, Brenner B, Paz B, Lanir N: Presence of Integrin alpha(IIb)beta3 in early gestation human trophoblasts. Possible involvement of fibrin as a matrix ligand. Thromb Res 2009; [Epub ahead of print].
  • 4
    Damsky CH, Werb Z: Signal transduction by integrin receptors for extracellular matrix: cooperative processing of extracellular information. Curr Opin Cell Biol 1992; 4:772781.
  • 5
    Quenby S, Anim-Somuah M, Kalumbi C, Farquharson R, Aplin JD: Different types of recurrent miscarriage are associated with varying patterns of adhesion molecule expression in endometrium. Reprod Biomed Online 2007; 14:224234.
  • 6
    Staun-Ram E, Goldman S, Shalev E: p53 Mediates epidermal growth factor (EGF) induction of MMP-2 transcription and trophoblast invasion. Placenta 2009; 30:10291036.
  • 7
    Bischof P, Meisser A, Campana A: Biochemistry and molecular biology of trophoblast invasion. Ann N Y Acad Sci 2001; 943:157162.
  • 8
    Hannan NJ, Salamonsen LA: CX3CL1 and CCL14 regulate extracellular matrix and adhesion molecules in the trophoblast: potential roles in human embryo implantation. Biol Reprod 2008; 79:5865.
  • 9
    Staun-Ram E, Goldman S, Gabarin D, Shalev E: Expression and importance of matrix metalloproteinase 2 and 9 (MMP-2 and -9) in human trophoblast invasion. Reprod Biol Endocrinol 2004; 2:59.
  • 10
    Librach CL, Feigenbaum SL, Bass KE, Cui TY, Verastas N, Sadovsky Y, Quigley JP, French DL, Fisher SJ: Interleukin-1 beta regulates human cytotrophoblast metalloproteinase activity and invasion in vitro. J Biol Chem 1994; 269:1712517131.
  • 11
    Meisser A, Cameo P, Islami D, Campana A, Bischof P: Effects of interleukin-6 (IL-6) on cytotrophoblastic cells. Mol Hum Reprod 1999; 5:10551058.
  • 12
    Roth I, Fisher SJ: IL-10 is an autocrine inhibitor of human placental cytotrophoblast MMP-9 production and invasion. Dev Biol 1999; 205:194204.
  • 13
    Tapia A, Salamonsen LA, Manuelpillai U, Dimitriadis E: Leukemia inhibitory factor promotes human first trimester extravillous trophoblast adhesion to extracellular matrix and secretion of tissue inhibitor of metalloproteinases-1 and -2. Hum Reprod 2008; 23:17241732.
  • 14
    Staun-Ram E, Shalev E: Human trophoblast function during the implantation process. Reprod Biol Endocrinol 2005; 3:56.
  • 15
    Hirabayashi J, Kasai KI: Evolution of animal lectins. Prog Mol Subcell Biol 1998; 19:4588.
  • 16
    Barondes SH, Castronovo V, Cooper DN, Cummings RD, Drickamer K, Feizi T, Gitt MA, Hirabayashi J, Hughes C, Kasai K, Leffler H, Liu FT, Lotan R, Mercurio AM, Monsigny M, Pillai S, Poirer F, Raz A, Rigby PWJ, Rini JM, Wang JL: Galectins: a family of animal beta-galactoside-binding lectins. Cell 1994; 76:597598.
  • 17
    Hirabayashi J, Hashidate T, Arata Y, Nishi N, Nakamura T, Hirashima M, Urashima T, Oka T, Futai M, Muller WE, Yagi F, Kasai K: Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. Biochim Biophys Acta 2002; 1572:232254.
  • 18
    Brewer CF: Lectin cross-linking interactions with multivalent carbohydrates. Adv Exp Med Biol 2001; 491:1725.
  • 19
    Smetana K, Holikova Z, Klubal R, Bovin NV, Dvorankova B, Bartunkova J, Liu FT, Gabius HJ: Coexpression of binding sites for A(B) histo-blood group trisaccharides with galectin-3 and Lag antigen in human Langerhans cells. J Leukoc Biol 1999; 66:644649.
  • 20
    Jeschke U, Karsten U, Wiest I, Schulze S, Kuhn C, Friese K, Walzel H: Binding of galectin-1 (gal-1) to the Thomsen–Friedenreich (TF) antigen on trophoblast cells and inhibition of proliferation of trophoblast tumor cells in vitro by gal-1 or an anti-TF antibody. Histochem Cell Biol 2006; 126:437444.
  • 21
    Jeschke U, Mayr D, Schiessl B, Mylonas I, Schulze S, Kuhn C, Friese K, Walzel H: Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen–Friedenreich (TF) antigen in normal, IUGR, preeclamptic and HELLP placentas. Placenta 2007; 28:11651173.
  • 22
    Jeschke U, Reimer T, Bergemann C, Wiest I, Schulze S, Friese K, Walzel H: Binding of galectin-1 (gal-1) on trophoblast cells and inhibition of hormone production of trophoblast tumor cells in vitro by gal-1. Histochem Cell Biol 2004; 121:501508.
  • 23
    Walzel H, Schulz U, Neels P, Brock J: Galectin-1, a natural ligand for the receptor-type protein tyrosine phosphatase CD45. Immunol Lett 1999; 67:193202.
  • 24
    Walzel H, Blach M, Hirabayashi J, Arata Y, Kasai K, Brock J: Galectin-induced activation of the transcription factors NFAT and AP-1 in human Jurkat T-lymphocytes. Cell Signal 2002; 14:861868.
  • 25
    Walzel H, Blach M, Hirabayashi J, Kasai KI, Brock J: Involvement of CD2 and CD3 in galectin-1 induced signaling in human Jurkat T-cells. Glycobiology 2000; 10:131140.
  • 26
    Fischer I, Schulze S, Kuhn C, Friese K, Walzel H, Markert UR, Jeschke U: Inhibiton of RET and JAK2 signals and upregulation of VEGFR3 phosphorylation in vitro by galectin-1 in trophoblast tumor cells BeWo. Placenta 2009; 30:10781082.
  • 27
    Van Der Leij J, Van Den Berg A, Blokzijl T, Harms G, Van Goor H, Zwiers P, Van Weeghel R, Poppema S, Visser L: Dimeric galectin-1 induces IL-10 production in T-lymphocytes: an important tool in the regulation of the immune response. J Pathol 2004; 204:511518.
  • 28
    Blois SM, Ilarregui JM, Tometten M, Garcia M, Orsal AS, Cordo-Russo R, Toscano MA, Bianco GA, Kobelt P, Handjiski B, Tirado I, Markert UR, Klapp BF, Poirier F, Szekeres-Bartho J, Rabinovich GA, Arck PC: A pivotal role for galectin-1 in fetomaternal tolerance. Nat Med 2007; 13:14501457.
  • 29
    Karimi K, Arck PC: Natural killer cells: keepers of pregnancy in the turnstile of the environment. Brain Behav Immun 2009; [Epub ahead of print].
  • 30
    Paclik D, Berndt U, Guzy C, Dankof A, Danese S, Holzloehner P, Rosewicz S, Wiedenmann B, Wittig BM, Dignass AU, Sturm A: Galectin-2 induces apoptosis of lamina propria T lymphocytes and ameliorates acute and chronic experimental colitis in mice. J Mol Med 2008; 86:13951406.
  • 31
    Stowell SR, Karmakar S, Stowell CJ, Dias-Baruffi M, McEver RP, Cummings RD: Human galectin-1, -2, and -4 induce surface exposure of phosphatidylserine in activated human neutrophils but not in activated T cells. Blood 2007; 109:219227.
  • 32
    Sturm A, Lensch M, Andre S, Kaltner H, Wiedenmann B, Rosewicz S, Dignass AU, Gabius HJ: Human galectin-2: novel inducer of T cell apoptosis with distinct profile of caspase activation. J Immunol 2004; 173:38253837.
  • 33
    Ozaki K, Inoue K, Sato H, Iida A, Ohnishi Y, Sekine A, Sato H, Odashiro K, Nobuyoshi M, Hori M, Nakamura Y, Tanaka T: Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-alpha secretion in vitro. Nature 2004; 429:7275.
  • 34
    Van Den Brule FA, Price J, Sobel ME, Lambotte R, Castronovo V: Inverse expression of two laminin binding proteins, 67LR and galectin-3, correlates with the invasive phenotype of trophoblastic tissue. Biochem Biophys Res Commun 1994; 201:388393.
  • 35
    Crider-Pirkle S, Billingsley P, Faust C, Hardy DM, Lee V, Weitlauf H: Cubilin, a binding partner for galectin-3 in the murine utero–placental complex. J Biol Chem 2002; 277:1590415912.
  • 36
    Bozic M, Petronijevic M, Milenkovic S, Atanackovic J, Lazic J, Vicovac L: Galectin-1 and galectin-3 in the trophoblast of the gestational trophoblastic disease. Placenta 2004; 25:797802.
  • 37
    Maquoi E, Van Den Brule FA, Castronovo V, Foidart JM: Changes in the distribution pattern of galectin-1 and galectin-3 in human placenta correlates with the differentiation pathways of trophoblasts. Placenta 1997; 18:433439.
  • 38
    Vicovac L, Jankovic M, Cuperlovic M: Galectin-1 and -3 in cells of the first trimester placental bed. Hum Reprod 1998; 13:730735.
  • 39
    Ochieng J, Warfield P: Galectin-3 binding potentials of mouse tumor EHS and human placental laminins. Biochem Biophys Res Commun 1995; 217:402406.
  • 40
    Ideo H, Seko A, Yamashita K: Galectin-4 binds to sulfated glycosphingolipids and carcinoembryonic antigen in patches on the cell surface of human colon adenocarcinoma cells. J Biol Chem 2005; 280:47304737.
  • 41
    Ideo H, Seko A, Yamashita K: Recognition mechanism of galectin-4 for cholesterol 3-sulfate. J Biol Chem 2007; 282:2108121089.
  • 42
    Bernerd F, Sarasin A, Magnaldo T: Galectin-7 overexpression is associated with the apoptotic process in UVB-induced sunburn keratinocytes. Proc Natl Acad Sci U S A 1999; 96:1132911334.
  • 43
    Leonidas DD, Vatzaki EH, Vorum H, Celis JE, Madsen P, Acharya KR: Structural basis for the recognition of carbohydrates by human galectin-7. Biochemistry 1998; 37:1393013940.
  • 44
    Demers M, Magnaldo T, St-Pierre Y: A novel function for galectin-7: promoting tumorigenesis by up-regulating MMP-9 gene expression. Cancer Res 2005; 65:52055210.
  • 45
    Langbein S, Brade J, Badawi JK, Hatzinger M, Kaltner H, Lensch M, Specht K, Andre S, Brinck U, Alken P, Gabius HJ: Gene-expression signature of adhesion/growth-regulatory tissue lectins (galectins) in transitional cell cancer and its prognostic relevance. Histopathology 2007; 51:681690.
  • 46
    Zick Y, Eisenstein M, Goren RA, Hadari YR, Levy Y, Ronen D: Role of galectin-8 as a modulator of cell adhesion and cell growth. Glycoconj J 2004; 19:517526.
  • 47
    Nishi N, Shoji H, Seki M, Itoh A, Miyanaka H, Yuube K, Hirashima M, Nakamura T: Galectin-8 modulates neutrophil function via interaction with integrin alphaM. Glycobiology 2003; 13:755763.
  • 48
    Choufani G, Ghanooni R, Decaestecker C, Delbrouck K, Simon P, Schuring MP, Zick Y, Hassid S, Gabius HJ, Kiss R: Detection of macrophage migration inhibitory factor (MIF) in human cholesteatomas and functional implications of correlations to recurrence status and to expression of matrix metalloproteinases-3/9, retinoic acid receptor-beta, and anti-apoptotic galectin-3. Laryngoscope 2001; 111:16561662.
  • 49
    Danguy A, Rorive S, Decaestecker C, Bronckart Y, Kaltner H, Hadari YR, Goren R, Zich Y, Petein M, Salmon I, Gabius HJ, Kiss R: Immunohistochemical profile of galectin-8 expression in benign and malignant tumors of epithelial, mesenchymatous and adipous origins, and of the nervous system. Histol Histopathol 2001; 16:861868.
  • 50
    Bidon N, Brichory F, Bourguet P, Le Pennec JP, Dazord L: Galectin-8: a complex sub-family of galectins (Review). Int J Mol Med 2001; 8:245250.
  • 51
    Popovici RM, Krause MS, Germeyer A, Strowitzki T, Von Wolff M: Galectin-9: a new endometrial epithelial marker for the mid- and late-secretory and decidual phases in humans. J Clin Endocrinol Metab 2005; 90:61706176.
  • 52
    Hirashima M, Kashio Y, Nishi N, Yamauchi A, Imaizumi TA, Kageshita T, Saita N, Nakamura T: Galectin-9 in physiological and pathological conditions. Glycoconj J 2004; 19:593600.
  • 53
    Kashio Y, Nakamura K, Abedin MJ, Seki M, Nishi N, Yoshida N, Nakamura T, Hirashima M: Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway. J Immunol 2003; 170:36313636.
  • 54
    Chabot S, Kashio Y, Seki M, Shirato Y, Nakamura K, Nishi N, Nakamura T, Matsumoto R, Hirashima M: Regulation of galectin-9 expression and release in Jurkat T cell line cells. Glycobiology 2002; 12:111118.
  • 55
    Wada J, Kanwar YS, Makino H: Relevance of extracellular matrix and its receptors in mammalian nephrogenesis revealed by metanephric organ culture system. Nephrol Dial Transplant 2002; 17(Suppl. 9):7577.
  • 56
    Asakura H, Kashio Y, Nakamura K, Seki M, Dai S, Shirato Y, Abedin MJ, Yoshida N, Nishi N, Imaizumi T, Saita N, Toyama Y, Takashima H, Nakamura T, Ohkawa M, Hirashima M: Selective eosinophil adhesion to fibroblast via IFN-gamma-induced galectin-9. J Immunol 2002; 169:59125918.
  • 57
    Than NG, Pick E, Bellyei S, Szigeti A, Burger O, Berente Z, Janaky T, Boronkai A, Kliman H, Meiri H, Bohn H, Than GN, Sumegi B: Functional analyses of placental protein 13/galectin-13. Eur J Biochem 2004; 271:10651078.
  • 58
    Ackerman SJ, Liu L, Kwatia MA, Savage MP, Leonidas DD, Swaminathan GJ, Acharya KR: Charcot–Leyden crystal protein (galectin-10) is not a dual function galectin with lysophospholipase activity but binds a lysophospholipase inhibitor in a novel structural fashion. J Biol Chem 2002; 277:1485914868.
  • 59
    Hotta K, Funahashi T, Matsukawa Y, Takahashi M, Nishizawa H, Kishida K, Matsuda M, Kuriyama H, Kihara S, Nakamura T, Tochino Y, Bodkin NL, Hansen BC, Matsuzawa Y: Galectin-12, an adipose-expressed galectin-like molecule possessing apoptosis-inducing activity. J Biol Chem 2001; 276:3408934097.
  • 60
    Yang RY, Hsu DK, Yu L, Ni J, Liu FT: Cell cycle regulation by galectin-12, a new member of the galectin superfamily. J Biol Chem 2001; 276:2025220260.
  • 61
    Visegrady B, Than NG, Kilar F, Sumegi B, Than GN, Bohn H: Homology modelling and molecular dynamics studies of human placental tissue protein 13 (galectin-13). Protein Eng 2001; 14:875880.
  • 62
    Than NG, Sumegi B, Than GN, Berente Z, Bohn H: Isolation and sequence analysis of a cDNA encoding human placental tissue protein 13 (PP13), a new lysophospholipase, homologue of human eosinophil Charcot–Leyden crystal protein. Placenta 1999; 20:703710.
  • 63
    Dunphy JL, Barcham GJ, Bischof RJ, Young AR, Nash A, Meeusen EN: Isolation and characterization of a novel eosinophil-specific galectin released into the lungs in response to allergen challenge. J Biol Chem 2002; 277:1491614924.
  • 64
    Stierstorfer B, Kaltner H, Neumuller C, Sinowatz F, Gabius HJ: Temporal and spatial regulation of expression of two galectins during kidney development of the chicken. Histochem J 2000; 32:325336.
  • 65
    French AT, Knight PA, Smith WD, Brown JK, Craig NM, Pate JA, Miller HR, Pemberton AD: Up-regulation of intelectin in sheep after infection with Teladorsagia circumcincta. Int J Parasitol 2008; 38:467475.
  • 66
    Ackerman SJ, Corrette SE, Rosenberg HF, Bennett JC, Mastrianni DM, Nicholson-Weller A, Weller PF, Chin DT, Tenen DG: Molecular cloning and characterization of human eosinophil Charcot–Leyden crystal protein (lysophospholipase) Similarities to IgE binding proteins and the S-type animal lectin superfamily. J Immunol 1993; 150:456468.
  • 67
    Clevers H: Wnt/beta-catenin signaling in development and disease. Cell 2006; 127:469480.
  • 68
    Logan CY, Nusse R: The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004; 20:781810.
  • 69
    Gordon MD, Nusse R: Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem 2006; 281:2242922433.
  • 70
    Hoppler S, Kavanagh CL: Wnt signalling: variety at the core. J Cell Sci 2007; 120:385393.
  • 71
    Sansom OJ, Reed KR, Van De Wetering M, Muncan V, Winton DJ, Clevers H, Clarke AR: Cyclin D1 is not an immediate target of beta-catenin following Apc loss in the intestine. J Biol Chem 2005; 280:2846328467.
  • 72
    He TC, Sparks AB, Rago C, Hermeking H, Zawel L, Da Costa LT, Morin PJ, Vogelstein B, Kinzler KW: Identification of c-MYC as a target of the APC pathway. Science 1998; 281:15091512.
  • 73
    Wu B, Crampton SP, Hughes CC: Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration. Immunity 2007; 26:227239.
  • 74
    Fodde R, Brabletz T: Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol 2007; 19:150158.
  • 75
    Wang Y: Wnt/Planar cell polarity signaling: a new paradigm for cancer therapy. Mol Cancer Ther 2009; 8:21032109.
  • 76
    Kuhl M: The WNT/calcium pathway: biochemical mediators, tools and future requirements. Front Biosci 2004; 9:967974.
  • 77
    Kim SE, Lee WJ, Choi KY: The PI3 kinase-Akt pathway mediates Wnt3a-induced proliferation. Cell Signal 2007; 19:511518.
  • 78
    Yun MS, Kim SE, Jeon SH, Lee JS, Choi KY: Both ERK and Wnt/beta-catenin pathways are involved in Wnt3a-induced proliferation. J Cell Sci 2005; 118:313322.
  • 79
    Hayashi K, Erikson DW, Tilford SA, Bany BM, Maclean JA 2nd, Rucker EB 3rd, Johnson GA, Spencer TE: Wnt genes in the mouse uterus: potential regulation of implantation. Biol Reprod 2009; 80:9891000.
  • 80
    Paria BC, Ma W, Tan J, Raja S, Das SK, Dey SK, Hogan BL: Cellular and molecular responses of the uterus to embryo implantation can be elicited by locally applied growth factors. Proc Natl Acad Sci U S A 2001; 98:10471052.
  • 81
    Mohamed OA, Jonnaert M, Labelle-Dumais C, Kuroda K, Clarke HJ, Dufort D: Uterine Wnt/beta-catenin signaling is required for implantation. Proc Natl Acad Sci USA 2005; 102:85798584.
  • 82
    Xie H, Tranguch S, Jia X, Zhang H, Das SK, Dey SK, Kuo CJ, Wang H: Inactivation of nuclear Wnt-beta-catenin signaling limits blastocyst competency for implantation. Development 2008; 135:717727.
  • 83
    Tulac S, Nayak NR, Kao LC, Van Waes M, Huang J, Lobo S, Germeyer A, Lessey BA, Taylor RN, Suchanek E, Giudice LC: Identification, characterization, and regulation of the canonical Wnt signaling pathway in human endometrium. J Clin Endocrinol Metab 2003; 88:38603866.
  • 84
    Tulac S, Overgaard MT, Hamilton AE, Jumbe NL, Suchanek E, Giudice LC: Dickkopf-1, an inhibitor of Wnt signaling, is regulated by progesterone in human endometrial stromal cells. J Clin Endocrinol Metab 2006; 91:14531461.
  • 85
    Hess AP, Hamilton AE, Talbi S, Dosiou C, Nyegaard M, Nayak N, Genbecev-Krtolica O, Mavrogianis P, Ferrer K, Kruessel J, Fazleabas AT, Fisher SJ, Giudice LC: Decidual stromal cell response to paracrine signals from the trophoblast: amplification of immune and angiogenic modulators. Biol Reprod 2007; 76:102117.
  • 86
    Galceran J, Farinas I, Depew MJ, Clevers H, Grosschedl R: Wnt3a−/−-like phenotype and limb deficiency in Lef1(−/−)Tcf1(−/−) mice. Genes Dev 1999; 13:709717.
  • 87
    Monkley SJ, Delaney SJ, Pennisi DJ, Christiansen JH, Wainwright BJ: Targeted disruption of the Wnt2 gene results in placentation defects. Development 1996; 122:33433353.
  • 88
    Parr BA, Cornish VA, Cybulsky MI, McMahon AP: Wnt7b regulates placental development in mice. Dev Biol 2001; 237:324332.
  • 89
    He S, Pant D, Schiffmacher A, Meece A, Keefer CL: Lymphoid enhancer factor 1-mediated Wnt signaling promotes the initiation of trophoblast lineage differentiation in mouse embryonic stem cells. Stem Cells 2008; 26:842849.
  • 90
    Pollheimer J, Loregger T, Sonderegger S, Saleh L, Bauer S, Bilban M, Czerwenka K, Husslein P, Knofler M: Activation of the canonical wingless/T-cell factor signaling pathway promotes invasive differentiation of human trophoblast. Am J Pathol 2006; 168:11341147.
  • 91
    Sonderegger S, Haslinger P, Sabri A, Leisser C, Otten JV, Fiala C, Knofler M: Wingless (Wnt)-3A induces trophoblast migration and matrix metalloproteinase-2 secretion through canonical Wnt signaling and protein kinase B/AKT activation. Endocrinology 2010; 151:211220.
  • 92
    Naito AT, Akazawa H, Takano H, Minamino T, Nagai T, Aburatani H, Komuro I: Phosphatidylinositol 3-kinase-Akt pathway plays a critical role in early cardiomyogenesis by regulating canonical Wnt signaling. Circ Res 2005; 97:144151.
  • 93
    Sonderegger S, Husslein H, Leisser C, Knofler M: Complex expression pattern of Wnt ligands and frizzled receptors in human placenta and its trophoblast subtypes. Placenta 2007; 28(Suppl. A):S97S102.
  • 94
    Grisaru-Granovsky S, Maoz M, Barzilay O, Yin YJ, Prus D, Bar-Shavit R: Protease activated receptor-1, PAR1, promotes placenta trophoblast invasion and beta-catenin stabilization. J Cell Physiol 2009; 218:512521.
  • 95
    Novakovic B, Rakyan V, Ng HK, Manuelpillai U, Dewi C, Wong NC, Morley R, Down T, Beck S, Craig JM, Saffery R: Specific tumour-associated methylation in normal human term placenta and first-trimester cytotrophoblasts. Mol Hum Reprod 2008; 14:547554.
  • 96
    Rena V, Angeletti S, Panzetta-Dutari G, Genti-Raimondi S: Activation of beta-catenin signalling increases StarD7 gene expression in JEG-3 cells. Placenta 2009; 30:876883.
  • 97
    Bromberg JF: Activation of STAT proteins and growth control. Bioessays 2001; 23:161169.
  • 98
    Ranger JJ, Levy DE, Shahalizadeh S, Hallett M, Muller WJ: Identification of a Stat3-dependent transcription regulatory network involved in metastatic progression. Cancer Res 2009; 69:68236830.
  • 99
    Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, Darnell JE Jr: Stat3 as an oncogene. Cell 1999; 98:295303.
  • 100
    Kamura T, Sato S, Haque D, Liu L, Kaelin WG Jr, Conaway RC, Conaway JW: The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev 1998; 12:38723881.
  • 101
    Hilton DJ: Negative regulators of cytokine signal transduction. Cell Mol Life Sci 1999; 55:15681577.
  • 102
    Fitzgerald JS, Poehlmann TG, Schleussner E, Markert UR: Trophoblast invasion: the role of intracellular cytokine signalling via signal transducer and activator of transcription 3 (STAT3). Hum Reprod Update 2008; 14:335344.
  • 103
    Suman P, Poehlmann TG, Prakash GJ, Markert UR, Gupta SK: Interleukin-11 increases invasiveness of JEG-3 choriocarcinoma cells by modulating STAT3 expression. J Reprod Immunol 2009; 82:111.
  • 104
    Dubinsky V, Poehlmann TG, Suman P, Gentile T, Markert UR, Gutierrez G: Role of Regulatory and Angiogenic Cytokines in Invasion of Trophoblastic Cells. Am J Reprod Immunol 2010; 63:193199.
  • 105
    Poehlmann TG, Fitzgerald JS, Meissner A, Wengenmayer T, Schleussner E, Friedrich K, Markert UR: Trophoblast invasion: tuning through LIF, signalling via Stat3. Placenta 2005; 26(Suppl. A):S37S41.
  • 106
    Ware CB, Horowitz MC, Renshaw BR, Hunt JS, Liggitt D, Koblar SA, Gliniak BC, McKenna HJ, Papayannopoulou T, Thoma B, Cheng L, Donovan PJ, Peschon JJ, Bartlett PF, Willis CR, Wright BD, Carpenter MK, Davison BL, Gearing DP: Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development 1995; 121:12831299.
  • 107
    Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Kontgen F, Abbondanzo SJ: Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 1992; 359:7679.
  • 108
    Antczak M, Van Blerkom J: Oocyte influences on early development: the regulatory proteins leptin and STAT3 are polarized in mouse and human oocytes and differentially distributed within the cells of the preimplantation stage embryo. Mol Hum Reprod 1997; 3:10671086.
  • 109
    Takeda K, Noguchi K, Shi W, Tanaka T, Matsumoto M, Yoshida N, Kishimoto T, Akira S: Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci USA 1997; 94:38013804.
  • 110
    Duncan SA, Zhong Z, Wen Z, Darnell JE Jr: STAT signaling is active during early mammalian development. Dev Dyn 1997; 208:190198.
  • 111
    Cross JC: Genetic insights into trophoblast differentiation and placental morphogenesis. Semin Cell Dev Biol 2000; 11:105113.
  • 112
    Carney EW, Prideaux V, Lye SJ, Rossant J: Progressive expression of trophoblast-specific genes during formation of mouse trophoblast giant cells in vitro. Mol Reprod Dev 1993; 34:357368.
  • 113
    Rossant J, Cross JC: Placental development: lessons from mouse mutants. Nat Rev Genet 2001; 2:538548.
  • 114
    Chan HY, Siu MK, Zhang HJ, Wong ES, Ngan HY, Chan KY, Cheung AN: Activated Stat3 expression in gestational trophoblastic disease: correlation with clinicopathological parameters and apoptotic indices. Histopathology 2008; 53:139146.
  • 115
    Busch S, Renaud SJ, Schleussner E, Graham CH, Markert UR: mTOR mediates human trophoblast invasion through regulation of matrix-remodeling enzymes and is associated with serine phosphorylation of STAT3. Exp Cell Res 2009; 315:17241733.
  • 116
    Kliman HJ: The placenta revealed. Am J Pathol 1993; 143:332336.
  • 117
    Bischof P, Meisser A, Campana A: Paracrine and autocrine regulators of trophoblast invasion--a review. Placenta 2000; 21(Suppl. A):S55S60.
  • 118
    Corvinus FM, Fitzgerald JS, Friedrich K, Markert UR: Evidence for a correlation between trophoblast invasiveness and STAT3 activity. Am J Reprod Immunol 2003; 50:316321.
  • 119
    Fitzgerald JS, Tsareva SA, Poehlmann TG, Berod L, Meissner A, Corvinus FM, Wiederanders B, Pfitzner E, Markert UR, Friedrich K: Leukemia inhibitory factor triggers activation of signal transducer and activator of transcription 3, proliferation, invasiveness, and altered protease expression in choriocarcinoma cells. Int J Biochem Cell Biol 2005; 37:22842296.
  • 120
    Goldberg GI, Strongin A, Collier IE, Genrich LT, Marmer BL: Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J Biol Chem 1992; 267:45834591.
  • 121
    Librach CL, Werb Z, Fitzgerald ML, Chiu K, Corwin NM, Esteves RA, Grobelny D, Galardy R, Damsky CH, Fisher SJ: 92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol 1991; 113:437449.
  • 122
    Bischof P, Haenggeli L, Campana A: Effect of leukemia inhibitory factor on human cytotrophoblast differentiation along the invasive pathway. Am J Reprod Immunol 1995; 34:225230.
  • 123
    Nachtigall MJ, Kliman HJ, Feinberg RF, Olive DL, Engin O, Arici A: The effect of leukemia inhibitory factor (LIF) on trophoblast differentiation: a potential role in human implantation. J Clin Endocrinol Metab 1996; 81:801806.
  • 124
    Naka T, Narazaki M, Hirata M, Matsumoto T, Minamoto S, Aono A, Nishimoto N, Kajita T, Taga T, Yoshizaki K, Akira S, Kishimoto T: Structure and function of a new STAT-induced STAT inhibitor. Nature 1997; 387:924929.
  • 125
    Laird SM, Tuckerman EM, Dalton CF, Dunphy BC, Li TC, Zhang X: The production of leukaemia inhibitory factor by human endometrium: presence in uterine flushings and production by cells in culture. Hum Reprod 1997; 12:569574.
  • 126
    Ledee-Bataille N, Lapree-Delage G, Taupin JL, Dubanchet S, Frydman R, Chaouat G: Concentration of leukaemia inhibitory factor (LIF) in uterine flushing fluid is highly predictive of embryo implantation. Hum Reprod 2002; 17:213218.
  • 127
    Jiang K, Chen Y, Jarvis JN: Soluble factors from LPS- and PHA-activated PBMC induce MAPK, Stat1 and Stat3 phosphorylation in primary cultures of human term placental trophoblasts: implications for infection and prematurity. Placenta 2007; 28:538542.
  • 128
    Jiang K, Krous LC, Knowlton N, Chen Y, Frank MB, Cadwell C, Centola M, Jarvis JN: Ablation of Stat3 by siRNA alters gene expression profiles in JEG-3 cells: a systems biology approach. Placenta 2009; 30:806815.
  • 129
    Boyle K, Robb L: The role of SOCS3 in modulating leukaemia inhibitory factor signalling during murine placental development. J Reprod Immunol 2008; 77:16.
  • 130
    Fitzgerald JS, Toth B, Jeschke U, Schleussner E, Markert UR: Knocking off the suppressors of cytokine signaling (SOCS): their roles in mammalian pregnancy. J Reprod Immunol 2009; 83:117123.
  • 131
    Zhao S, Gu Y, Dong Q, Fan R, Wang Y: Altered interleukin-6 receptor, IL-6R and gp130, production and expression and decreased SOCS-3 expression in placentas from women with pre-eclampsia. Placenta 2008; 29:10241028.
  • 132
    Redline RW, Patterson P: Pre-eclampsia is associated with an excess of proliferative immature intermediate trophoblast. Hum Pathol 1995; 26:594600.
  • 133
    Reister F, Kingdom JC, Ruck P, Marzusch K, Heyl W, Pauer U, Kaufmann P, Rath W, Huppertz B: Altered protease expression by periarterial trophoblast cells in severe early-onset preeclampsia with IUGR. J Perinat Med 2006; 34:272279.
  • 134
    Huppertz B, Peeters LL: Vascular biology in implantation and placentation. Angiogenesis 2005; 8:157167.
  • 135
    Kaufmann P, Black S, Huppertz B: Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 2003; 69:17.
  • 136
    Jauniaux E, Watson AL, Hempstock J, Bao YP, Skepper JN, Burton GJ: Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure. Am J Pathol 2000; 157:21112122.
  • 137
    Burton GJ, Watson AL, Hempstock J, Skepper JN, Jauniaux E: Uterine glands provide histiotrophic nutrition for the human fetus during the first trimester of pregnancy. J Clin Endocrinol Metab 2002; 87:29542959.
  • 138
    Brayman M, Thathiah A, Carson DD: MUC1: a multifunctional cell surface component of reproductive tissue epithelia. Reprod Biol Endocrinol 2004; 2:4.
  • 139
    Burton GJ, Jauniaux E, Charnock-Jones DS: Human early placental development: potential roles of the endometrial glands. Placenta 2007; 28(Suppl. A):S64S69.
  • 140
    Moser G, Gauster M, Orendi K, Glasner A, Theuerkauf R, Huppertz B: Endoglandular trophoblast, an alternative route of trophoblast invasion? Analysis with novel confrontation co-culture models. Hum Reprod (Under revision).
  • 141
    Benirschke K, Kaufmann P, Baergen R: Pathology of the Human Placenta, 5th edn. New York, Springer, 2006.